Aug 29 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX :
* UNFRANKED FINAL DIVIDEND OF $0.02 PER ORDINARY SHARE HAS BEEN DECLARED
* FY NET PROFIT ATTRIBUTABLE UP 86% TO $13.2 MILLION
* FY REVENUES FROM ORDINARY ACTIVITIES UP 52% TO $25.8 MILLION
Aug 29 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX :
* UNFRANKED FINAL DIVIDEND OF $0.02 PER ORDINARY SHARE HAS BEEN DECLARED
* FY NET PROFIT ATTRIBUTABLE UP 86% TO $13.2 MILLION
* FY REVENUES FROM ORDINARY ACTIVITIES UP 52% TO $25.8 MILLION